Collaboration brings technology and consumables together for bioprinting for research applications.
Lonza brings a broad range of high-quality human-derived primary cells, stem cells and supporting culture media ideally suited for 3D bioprinting.
Allevi to offer these components as part of its package of bioprinters, bioinks and software.
Basel, Switzerland and Philadelphia, USA– Allevi and Lonza announce collaboration to bring the elements needed for 3D bioprinting together. Combining Lonza’s primary cells and media with Allevi’s 3D bioprinters and bioink production capabilities will empower researchers with the tools needed for plug-and-play bioprinting.
Allevi is dedicated to providing high-quality materials for every step of the 3D bioprinting workflow, making it easy to design, engineer, and manufacture 3D tissues. Their 3D bioprinters and bioinks are used by leading researchers globally in research drug discovery and tissue engineering.
Lonza Biosciences, a global leader in cell biology solutions, offers a broad range of high-quality human-derived primary cells, stem cells and supporting culture media that are ideally suited for 3D cell culture and 3D bioprinting.
3D bioprinting is a promising technology for engineering of complex 3D tissues needed in many areas ofin vitrodrug discovery research. High-quality cells are the essential building block for creating 3D bioprinting constructs and can be printed in physiological relevant patterns using this technology.
Lonza collaborates with selected providers of 3D printing technology to bring the best cell and media tools to 3D bioprinting applications. Allevi customers will now have access to Lonza primary cells and media for use in Allevi’s protocols for 3D bioprinting.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
Lonza is an integrated solutions provider that creates value along the Healthcare Continuum® . Through our Pharma Biotech & Nutrition segment and our Specialty Ingredients segment businesses, we harness science and technology to serve markets along this continuum. We focus on creating a healthy environment, promoting a healthier lifestyle and preventing illness through consumers' preventive healthcare, as well as improving patient healthcare by supporting our customers to deliver innovative medicines that help treat or even cure severe diseases.